Skip to main content
Clinical Trials/EUCTR2011-000750-37-NL
EUCTR2011-000750-37-NL
Active, not recruiting
Not Applicable

A randomised clinical trial on the effectiveness of Emla and Rapydan for prevention of vena punction-induced pain in children. - Rapydan versus Emla in prevention of vena punction-induced pain

Isala Klinieken0 sites200 target enrollmentNovember 21, 2011

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Venipuncture, especially in children, is associated with pain and discomfort. For this reason, often use a local anesthetic.
Sponsor
Isala Klinieken
Enrollment
200
Status
Active, not recruiting
Last Updated
14 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 21, 2011
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Isala Klinieken

Eligibility Criteria

Inclusion Criteria

  • Indication for vena puncture.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 200
  • F.1\.2 Adults (18\-64 years) no
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) no
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • Allergy to the product and a plaster

Outcomes

Primary Outcomes

Not specified

Similar Trials